Cryo-Cell International, Inc.
CCEL
$7.17
$0.14262.03%
| Weiss Ratings | CCEL - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D+ | |||
| Rating Factors | CCEL - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CCEL - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.33 | |||
| Price History | CCEL - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -5.50% | |||
| 30-Day Total Return | -2.66% | |||
| 60-Day Total Return | -15.82% | |||
| 90-Day Total Return | 22.99% | |||
| Year to Date Total Return | 0.44% | |||
| 1-Year Total Return | 25.01% | |||
| 2-Year Total Return | 102.80% | |||
| 3-Year Total Return | 7.24% | |||
| 5-Year Total Return | 21.49% | |||
| 52-Week High % Change | -25.98% | |||
| 52-Week Low % Change | 31.40% | |||
| Price | CCEL - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $9.50 | |||
| 52-Week Low Price | $5.35 | |||
| 52-Week Low Price (Date) | Mar 15, 2024 | |||
| 52-Week High Price (Date) | May 15, 2024 | |||
| Valuation | CCEL - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 56.82M | |||
| Enterprise Value | 66.26M | |||
| Price/Earnings (TTM) | 151.51 | |||
| Earnings Per Share (TTM) | 0.05 | |||
| Earnings Per Share Growth | -104.02% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.77 | |||
| Price/Book (Q) | -4.30 | |||
| Enterprise Value/Revenue (TTM) | 2.07 | |||
| Price | $7.17 | |||
| Enterprise Value/EBITDA (TTM) | 14.77 | |||
| Enterprise Value/EBIT | 17.48 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | CCEL - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 8.07M | |||
| Dividend Yield | 7.11% | |||
| Div. Per Share (Most Recent) | $0.25 | |||
| Dividend Per Share (TTM) | $0.50 | |||
| Payout Ratio (TTM) | 502.49% | |||
| Dividend Per Share (Most Recent) | $0.25 | |||
| Company Info | CCEL - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 813 749 2100 | |||
| Address | 700 Brooker Creek Boulevard Oldsmar, FL 34677 | |||
| Website | www.cryo-cell.com | |||
| Country | United States | |||
| Year Founded | 1989 | |||
| Profitability | CCEL - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 11.85% | |||
| Profit Margin | 1.25% | |||
| Management Effectiveness | CCEL - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 3.76% | |||
| Return on Equity | -- | |||
| Income Statement | CCEL - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 31.99M | |||
| Total Revenue (TTM) | 31.99M | |||
| Revenue Per Share | $3.97 | |||
| Gross Profit (TTM) | 24.04M | |||
| EBITDA (TTM) | 4.48M | |||
| EBIT (TTM) | 3.79M | |||
| Net Income (TTM) | 402.10K | |||
| Net Income Avl. to Common (TTM) | 402.10K | |||
| Total Revenue Growth (Q YOY) | 1.87% | |||
| Earnings Growth (Q YOY) | 83.36% | |||
| EPS Diluted (TTM) | 0.05 | |||
| EPS Diluted Growth (Q YOY) | 82.91% | |||
| Balance Sheet | CCEL - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.50M | |||
| Cash Per Share (Q) | $0.43 | |||
| Total Current Assets (Q) | 12.55M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -13.22M | |||
| Current Ratio (Q) | 0.581 | |||
| Book Value Per Share (Q) | -$1.64 | |||
| Total Assets (Q) | 64.68M | |||
| Total Current Liabilities (Q) | 21.60M | |||
| Total Debt (Q) | 12.93M | |||
| Total Liabilities (Q) | 77.89M | |||
| Total Common Equity (Q) | -13.22M | |||
| Cash Flow | CCEL - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -4.88M | |||
| Cash from Financing (TTM) | -979.10K | |||
| Net Change in Cash (TTM) | 154.80K | |||
| Levered Free Cash Flow (TTM) | -3.05M | |||
| Cash from Operations (TTM) | 6.01M | |||
